Adalimumab Stocks List

Adalimumab Stocks Recent News

Date Stock Title
Mar 27 VTRS Viatris Inc. (VTRS) R&D Event (Transcript)
Mar 27 ABBV AbbVie: An Undervalued Giant
Mar 27 VTRS Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline
Mar 26 ABBV AbbVie (ABBV) to Buy Landos to Strengthen Autoimmune Portfolio
Mar 26 ABBV 20 Cloudiest Cities in the U.S., Ranked
Mar 25 ABBV AbbVie (ABBV) Advances While Market Declines: Some Information for Investors
Mar 25 ABBV Why Is Ulcerative Colitis-Focused Landos Biopharma Stock Trading Higher On Monday?
Mar 25 ABBV 30 Countries with Highest Proportion of Older Adults
Mar 25 ABBV Why AbbVie (ABBV) is a Great Dividend Stock Right Now
Mar 25 ABBV Landos shares rocket 170% on AbbVie takeover deal
Mar 25 ABBV Allergan Aesthetics Launches "Moving the Needle on Ethics" to Elevate the Conversation Around Ethics in Aesthetics
Mar 25 ABBV AbbVie to bolster immunity illness drug pipeline with Landos deal
Mar 25 ABBV AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
Mar 25 ABBV AbbVie to buy immune drug developer Landos
Mar 24 ABBV 12 Best Biotech Penny Stocks to Invest In
Mar 24 ABBV 13 Best Dividend-Paying Stocks Under $15
Mar 22 ABBV Insider Sell: EVP, Chief Business/Strategy Officer Nicholas Donoghoe Sells 21,082 Shares of ...
Mar 22 ABBV FDA grants full approval to AbbVie/ImmunoGen drug Elahere
Mar 22 ABBV UPDATE 1-US FDA grants full approval to AbbVie's ovarian cancer therapy
Mar 22 ABBV U.S. Food and Drug Administration (FDA) Grants Full Approval for ELAHERE® (mirvetuximab soravtansine-gynx) for Certain Ovarian Cancer Patients
Adalimumab

Adalimumab, sold under the brand name Humira, among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis. Use is generally only recommended in people who have not responded to other treatments. It is administered by injection under the skin.Common side effects include upper respiratory tract infections, pain at the site of injection, rash, and headache. Other side effects may include serious infections, cancer, anaphylaxis, reactivation of hepatitis B, multiple sclerosis, heart failure, liver failure, and aplastic anemia. Use during pregnancy is not recommended, but some sources show use during breastfeeding may be safe. Adalimumab is a disease-modifying antirheumatic drug and monoclonal antibody that works by inactivating tumor necrosis factor-alpha (TNFα).Adalimumab was approved for medical use in the United States in 2002. It is on the World Health Organization's List of Essential Medicines. It is available as a biosimilar medication. In 2017, it was the 169th most commonly prescribed medication in the United States, with more than three million prescriptions.

Browse All Tags